Furthermore, the relative gene expression of Bcl-2 was significantly downregulated in OVCAR-3 cancer cells treated with CMB for 24 h or 48 h to 0.70 and 0.33, respectively, compared to untreated control cells. The gene discussed is BCL2; the disease is cancer.